ايبرانس 125 مجم 21 كبسولة

ما هو دواء ايبرانس 125 مجم 21 كبسولة

جرعة دواءايبرانس 125 مجم 21 كبسولة

يستعمل دواء ايبرانس 125 مجم 21 كبسولةibrance 125 mg 21 caps. antineoplastic agent.cyclin-dependent kinase inhibitor antineoplastic agent.cyclin-dependent kinase inhibitor

pharmacology - -palbociclib is a reversible small molecule cyclin-dependent kinase (cdk) inhibitor which is selective for cdk 4 and 6. cdks have a role in regulating progression through the cell cycle at the g1/s phase by blocking retinoblastoma (rb) hyperphosphorylation (finn 2015). palbociclib reduces proliferation of breast cancer cell lines by preventing progression from the g1 to the s cell cycle phase. the combination of palbociclib with an antiestrogen provides for increased inhibition of rb phosphorylation downstream signaling and tumor growth compared with each agent alone. - -indications --breast cancer advanced (initial endocrine-based therapy): treatment of hormone receptor (hr)-positive human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer (in combination with an aromatase inhibitor) in postmenopausal women as initial endocrine-based therapy. - -breast cancer advanced (with disease progression following endocrine therapy).

تركيبة دواءايبرانس 125 مجم 21 كبسولةibrance 125 mg 21 caps.

يتركب هذا الدواء من :palbociclib